S.I. No. 533/2017 - Misuse of Drugs (Designation) (Amendment) Order 2017

1. (1) This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order 2017.

(2) The Principal Order and this Order may be cited together as the Misuse of Drugs (Designation) Orders 2017.

2. In this Order “Principal Order” means the Misuse of Drugs (Designation) Order 2017 (

S.I. No. 174 of 2017

).

3. Paragraph 1(

a

) of Schedule 1 to the Principal Order is amended—

(

a

) by inserting “3,4-Dichloro-

N

-(2-dimethylamino-cyclohexyl)-

N

-methyl-benzamide (otherwise known as U-47700)” after “3,4-Dichloro-

N

-[[1-(dimethylamino) cyclohexyl]methyl]benzamide (otherwise known as AH-7921)”,

(

b

) by inserting “Ethyl phenyl(piperidin-2-yl) acetate (otherwise known as Ethylphenidate)” after “3-Dimethylheptyl-11-hydroxyhexahydrocannabinol”,

(

c

) by inserting “[1-(5-Fluoropentyl)-1

H

-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (otherwise known as XLR-11)” after “Etryptamine”, and

(

d

) by inserting “

N

-Methyl-1-(thiophen-2-yl) propan-2-amine (otherwise known as Methiopropamine)” after “1-(4-Methylphenyl)-2-methylaminopropan-1-one”.

GIVEN under my Hand,

24 November 2017.

CATHERINE BYRNE,

Minister of State at the Department of Health.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation).

The purpose of this Order is to amend the Misuse of Drugs (Designation) Order 2017 by inserting into Schedule 1 to that Order the following

3,4-Dichloro-

N

-(2-dimethylamino-cyclohexyl)-

N

-methyl-benzamide (otherwise known as U-47700);

Ethyl phenyl(piperidin-2-yl) acetate (otherwise known as Ethylphenidate);

[1-(5-Fluoropentyl)-1

H

-indol-3-yl](2,2,3,3-tetramethylcyclopropyl) methanone (otherwise known as XLR-11); and

N

-Methyl-1-(thiophen-2-yl) propan-2-amine (otherwise known as Methiopropamine).

This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order 2017.

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of

1

st December

, 2017.

I, Catherine Byrne, Minister of State at the Department of Health, in exercise of the powers conferred on me by

section 13

of the

Misuse of Drugs Act 1977

(No. 12 of 1977) and the Health (Delegation of Ministerial Functions) (No. 4) Order 2017 (

S.I. No. 339 of 2017

), hereby order as follows